Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Wed, 30.09.2020
MBH Corporation Plc
MBH Corporation PLC builds on 2019 growth momentum with revenues climbing 31% in first half of 2020
Revenues up by 31% to GBP27.4 million in 1H 2020, despite impact of Covid-19 pandemic
EBITDA increase by 13% to GBP1.5 million year-on-year
MBH continues growth course with 3 acquisitions in 1H 2020 and 8 as of 2nd September 2020
MBH raises M&a [ … ]
Wed, 30.09.2020
Bitcoin Group SE
Bitcoin Group SE publishes Half-Year Report 2020 - dynamic growth despite challenging environment
- Sales increased sharply by more than 153 percent to TEUR 6,228
- EBITDA more than tripled to TEUR 4,177 (previous year: TEUR 1,231)
- Management confirms all forecasts
Herford, September 30, 2020 - Bitcoin Group SE (ISIN DE000A1TNV91) today pres [ … ]
Wed, 30.09.2020
NEXR Technologies SE
NeXR Technologies SE sales activities restricted by COVID-19 in first half of 2020 - B2B virtual reality application NeXR Seminar is the future of learning
Berlin, 30 September 2020
NeXR Technologies SE (XETRA: 99SC) today published its financial report for the first half-year 2020. Massive restrictions in public life and wide contact restriction [ … ]
Wed, 30.09.2020
PharmaSGP Holding SE
PharmaSGP publishes H1 Report 2020 and confirms strong performance and positive outlook for the full year
- Group revenues rise significantly by 7.2% to € 33.8 million in H1 2020, adjusted1 EBIT increases disproportionately by 17.7% to € 10.6 million
- Systematic expansion of the product portfolio and advancing internationalization as key growth [ … ]
Wed, 30.09.2020
KROMI Logistik AG
KROMI publishes 2019/2020 annual report
- KROMI achieves significantly improved, slightly positive EBIT despite Corona pandemic
- After 4 percent revenue growth in H1, significant Corona-related revenue decline in Q4
- Total revenues in 2019/2020 down by around 7 percent compared to previous year
- EBIT increased by around EUR 1.3 million yea [ … ]
Wed, 30.09.2020
Conzzeta
Bystronic takes full control of DNE Laser
Enhanced flexibility to deploy growth strategy
Zurich, September 30, 2020 - As part of the growth strategy for its Bystronic business unit, Conzzeta announces the signing of an equity transfer agreement to increase the participation in DNE Laser, Shenzhen, China, from 70% to 100%.
With the acquisition of [ … ]
Wed, 30.09.2020
Relief Therapeutics Holdings AG
EQS Group-News: Relief Therapeutics Holdings AG
/ Key word(s): Miscellaneous
NeuroRx and Relief Therapeutics Establish Supply and Distribution Agreements for RLF-100(TM) (aviptadil)
30.09.2020 / 07:00
NeuroRx and Relief Therapeutics Establish Supply and Distribution Agreements for RLF-100(TM) (aviptadil)
Development partners es [ … ]
Wed, 30.09.2020
PIERER Mobility AG
Corporate News
Wels, 30 September 2020PIERER Mobility AG:
- Intensification of the joint venture with CFMOTO in China
- Strengthening the presence in China and expanding market shares
Intensification of the joint venture with CFMOTO in China - Strengthening the presence in China and expanding market shares
The joint venture with CFMOTO is be [ … ]
Tue, 29.09.2020
Media and Games Invest plc
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE [ … ]
Tue, 29.09.2020
CureVac
CureVac Initiates Phase 2a Clinical Trial of COVID-19 Vaccine Candidate
- Study conducted in Peru and Panama
- Trial involves 690 participants, including older adults
- Evaluation of safety, reactogenicity and immunogenicity
TÜBINGEN, Germany/ BOSTON, USA - September 29, 2020 - CureVac N.V. (Nasdaq: CVAC), a clinical-stage biopharmaceutical c [ … ]